Catapult Group International Ltd (CAZGF)

Market Cap	1.14B
Revenue (ttm)	116.53M
Net Income (ttm)	-8.81M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	232
Open	4.290
Previous Close	4.250
Day's Range	4.250 - 4.290
52-Week Range	1.170 - 4.580
Beta	1.62
RSI	64.00
Earnings Date	May 21, 2025

About Revance Therapeutics

Catapult Group International Ltd, a sports science and analytics company, development and supply of technologies that improve the performance of athletes and sports teams in Australia, Europe, the Middle East, Africa, the Asia Pacific, and the Americas. It operates in three segments: Performance & Health; Tactics & Coaching; and Media & Other. The company engages in the development and sale of performance and health technology solutions, including wearable tracking and analytics, and athlete monitoring software solutions; tactical and coaching ...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 2006
• Employees: 440
• Stock Exchange: OTCMKTS
• Ticker Symbol: CAZGF

Financial Performance

In 2024, CAZGF's revenue was $116.53 million, an increase of 16.52% compared to the previous year's $100.00 million. Losses were -$8.81 million, -47.27% less than in 2023.